• Health & Medicine

Non-Hodgkin lymphoma treatment gets the green light for NHS use in England 

The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma. The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma.

20 August 2020

• Health & Medicine

150% surge in skin cancer deaths since 70s

According to figures, melanoma skin cancer deaths have been increasing dramatically in the UK, with the rate rising two and halftimes since the 1970s. According to figures, melanoma skin cancer deaths have been increasing dramatically in the UK, with the rate rising two and halftimes since the 1970s.

20 August 2020

• For Supporters

Join Cancer Research UK for A Very 2020 Race for Life 5k event

Cancer Research UK is encouraging people to sign up to a 5k event on 26 September, called ‘A Very 2020 Race for Life’, and raise money for life-saving research. Cancer Research UK is encouraging people to sign up to a 5k event on 26 September, called ‘A Very 2020 Race for Life’, and raise money for life-saving research.

17 August 2020

• Health & Medicine

Sponge on a string test to transform oesophageal cancer diagnosis

A ‘sponge on a string’ pill test can identify ten times more people with Barrett’s oesophagus than the usual GP route A ‘sponge on a string’ pill test can identify ten times more people with Barrett’s oesophagus than the usual GP route

31 July 2020

• Charity News

Cancer Research UK, University of Southampton and Touchlight Genetics partner to develop head and neck cancer vaccine

Cancer Research UK, the University of Southampton and Touchlight Genetics, a London based biotechnology company announce a new clinical development partnership Cancer Research UK, the University of Southampton and Touchlight Genetics, a London based biotechnology company announce a new clinical development partnership

29 July 2020

• Health & Medicine

One third of cancer patients say coronavirus has impacted their treatment

One in three cancer patients said their treatment was impacted by the effects of COVID-19 on the health system, according to survey results. One in three cancer patients said their treatment was impacted by the effects of COVID-19 on the health system, according to survey results.

28 July 2020

• Health & Medicine

UK public urged to take care this summer as around 40% spending more time in the sun since COVID-19 lockdown

New figures from Cancer Research UK and NIVEA SUN suggest that people are not protecting themselves properly from the sun in the UK. New figures from Cancer Research UK and NIVEA SUN suggest that people are not protecting themselves properly from the sun in the UK.

22 July 2020

• Health & Medicine

44% rise in patients waiting for tests to diagnose bowel, stomach, bladder and oesophageal cancer

55,500 more people are waiting to get tests used to diagnose four common cancers compared to last year. 55,500 more people are waiting to get tests used to diagnose four common cancers compared to last year.

20 July 2020

• Health & Medicine

Targeted treatment for leukaemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.   The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.  

16 July 2020

• For Supporters
• Charity News

Cancer Research UK plans to rebuild and adapt to changed world following £300m drop in income

Cancer Research UK is making difficult decisions to significantly reduce how much it spends on beating cancer, its operations and the number of staff. Cancer Research UK is making difficult decisions to significantly reduce how much it spends on beating cancer, its operations and the number of staff.

15 July 2020

• Health & Medicine

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England. The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

10 July 2020

• Policy & Insight
• Health & Medicine

Urgent cancer referrals being turned down during coronavirus pandemic 

Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic. Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic.

8 July 2020